Amifostine in Treating Patients With Myelodysplastic Syndrome

Completed · Phase 2

Conditions studied: Myelodysplastic Syndromes

In brief

RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with myelodysplastic syndrome.

Key facts

Study ID

NCT00003048

Run by

M.D. Anderson Cancer Center

People needed

12

Starts

1997-06-05

Expected to finish

2001-02-12

Last updated by the study team

2018-10-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.